PT  - JOURNAL ARTICLE
AU  - Khalid, Rojeen Chalabi
AU  - Jamal, Tamara Bassam
AU  - Mahdi, Sara Ardalan
AU  - Mustafa, Abdullah Saeed
TI  - Prevalence of long covid-19 among pediatric age group in Duhok city, Kurdistan region, Iraq
AID  - 10.1101/2023.08.05.23293695
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.08.05.23293695
4099  - http://medrxiv.org/content/early/2023/08/09/2023.08.05.23293695.short
4100  - http://medrxiv.org/content/early/2023/08/09/2023.08.05.23293695.full
AB  - Background A range of persistent symptoms that can develop in some people after they have recovered from acute COVID-19, is known as Long COVI-19. It can affect people of all ages and severity of initial illness, including those who had mild or asymptomatic infections.. Dealing with Long COVID-19 can be challenging, and the best course of action will depend on the specific symptoms and individual needs of the patient. This study aims to detect the prevalence of long covid-19 among the children who tested positive for IgG test. If IgG antibodies are detected in a person’s blood sample, it suggests that they have been infected with SARS-CoV-2 at some point in the past and their immune system has responded by producing antibodies against the virus.Material and Methodology From (October 22nd till December 4th 2022) the data of this study had been collected through a face-to-face interview with withdrawing blood samples for serum Immunoglobin-G test in laboratory of (General zakho Teaching Hospital in Zakho) and (Hevi Pediatric Teaching Hospital in Duhok). A total number of 330 children aged between 5-12 ages participated in this study. Moreover, If IgG antibodies are detected in a person’s blood sample, it suggests that they have been infected with SARS-CoV-2 at some point in the past and their immune system has responded by producing antibodies against the virus.Results (Fatigue 12/ 85.7%), (cough 10/ 71.4%), (post exertional malaise 5/ 35.7%) were the most detected symptoms among the 14 positive patients. Followed by (headache, dizziness, hair loss, loss of appetite, loss/change in smell and taste, difficulty in sleep, mood change, abdominal pain, change in bowel habits, chest pain) to lesser extent.Conclusion long-term sequelae of Covid-19 now is becoming a challenge that needs more continued research and collaboration among healthcare providers, researchers, and patients are essential. Long COVID-19 is a public health concern that requires ongoing attention and resources, as well as support for those who are experiencing its debilitating effects. Out of 330 children only 4.6% (14 children) were experiencing long covid-19 symptoms for more than 4 weeks after acute infections in Duhok city.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Ethics and scientific committee of college of medicine, university of zakho, Kurdistan region, Iraq. All the subjects included in this study have been informed that their personal data will not be shared, and a formal consent has been taken from each individual.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript